A comparison between two strategies for monitoring hepatic function during antituberculous therapy.
about
Mycobactericidal activity of sutezolid (PNU-100480) in sputum (EBA) and blood (WBA) of patients with pulmonary tuberculosisEpidemiology, Diagnosis and Management of Extra-Pulmonary Tuberculosis in a Low-Prevalence Country: A Four Year Retrospective Study in an Australian Tertiary Infectious Diseases UnitHepatitis C and not Hepatitis B virus is a risk factor for anti-tuberculosis drug induced liver injuryViral hepatitis prevalence in patients with active and latent tuberculosis.Drug-induced liver injury from antituberculous treatment: a retrospective study from a large TB centre in the UK.Early monitoring for detection of antituberculous drug-induced hepatotoxicityOutcome and determinants of mortality in 269 patients with combination anti-tuberculosis drug-induced liver injury.Evaluation of screening methods for identification of patients with chronic rheumatological disease requiring tuberculosis chemoprophylaxis prior to commencement of TNF-α antagonist therapy.Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study.Daily vs Intermittent Antituberculosis Therapy for Pulmonary Tuberculosis in Patients With HIV: A Randomized Clinical Trial.N-acetyltransferase 2 (NAT2) genotype as a risk factor for development of drug-induced liver injury relating to antituberculosis drug treatment in a mixed-ethnicity patient group
P2860
Q28537839-C738A24A-9B70-4F05-8083-FA215645B82EQ28550663-C6D4BDA4-9163-4006-B2DF-137D54874370Q35911420-9020E435-AFC3-49F9-90AB-31190898116CQ35925537-84A93ED2-F6A7-4A95-960A-B71FCDFAA044Q36322465-2641120E-017D-4C24-BDDF-AB522DFCA44FQ36461154-6DC3A49A-A367-453E-B9E9-7B280D53AF0EQ45909196-5AC8DD60-62A9-4151-9585-0DEE55CF75EBQ47119702-954BE1A8-9FBA-47E9-BD14-14B4817856C0Q52625145-CDE2AB3E-B3FA-4B1D-AEDB-24469716018FQ52672810-2E4B608A-104F-48B6-A5E7-7B155EB67DA4Q57302643-607A3027-6A49-4FDC-AB46-6091C1E311E6
P2860
A comparison between two strategies for monitoring hepatic function during antituberculous therapy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
A comparison between two strat ...... uring antituberculous therapy.
@en
type
label
A comparison between two strat ...... uring antituberculous therapy.
@en
prefLabel
A comparison between two strat ...... uring antituberculous therapy.
@en
P2093
P2860
P50
P1476
A comparison between two strat ...... uring antituberculous therapy.
@en
P2093
Aran Singanayagam
Dalia Abdel-Aziz
David W Connell
Jaideep Dhariwal
Kerry Munro
Melissa Wickremasinghe
Peter M George
Philip L Molyneaux
P2860
P304
P356
10.1164/RCCM.201105-0850OC
P407
P577
2011-12-28T00:00:00Z